Inhaled Corticosteroids and Secondary Adrenal Insufficiency
Open accessThe DOI matches its Crossref record; 73 of the 75 references it cites were found in a registry or an index.
Abstract
Inhaled corticosteroids (ICS) have been used as first line treatment of asthma for many decades. ICS are a form of exogenous glucocorticosteroids that can suppress the endogenous production of glucocorticosteroids, a condition known as adrenal suppression (AS). As a result, cessation, decreasing the dose or changing the type of ICS may trigger features of adrenal insufficiency (AI). AI may cause a spectrum of presentations varying from vague symptoms of fatigue to potentially life threatening acute adrenal crises. This article reviews the current literature on ICS and AI particularly in adults (although majority of data available is from the paediatric population). It aims to increase awareness of the potential risk of AI associated with ICS use, delineate the pathogenesis of AI and to provide recommendations on screening and management. From our literature review, we have found numerous case reports that have shown an association between ICS and AI particularly in children and patients using high doses. However, there have also been reports of AI in adults as well as in patients using low to moderate doses of ICS. To conclude, we recommend screening for AI in select patient groups with an initial early morning serum cortisol. If results are abnormal, more definitive testing such as the low dose corticotropin stimulation test may be done to confirm the diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. (1) HPA axis response to acute and chronic stress leading from inflammation. CRH-corticotrophin releasing hormone, ACTHadrenocorticotrophic releasing hormone, IL-interleukin, TNF-tumor necrosis factor. Green arrows indicate activation, red arrows indicate suppression. HPA axis gets activated by specific cytokines released during inflammation (IL-1, IL6). IL-6 has been recognized as important in innate immune response [59]. Acute inflammation leads to activation of HPA axis and marked and prolonged elevation of plasma ACTH and cortisol, however chronic activation of HPA axis leads to a blunted ACTH and cortisol response as a protective adaptation mechanism [60]. Exogenous corticosteroids lead to suppression of the HPA axis in the same manner as cortisol that inhibits both CRH and ACTH synthesis [61].](https://figures.cochat.ai/paper-figures/b6956858a2d54635ae7c99d897edcca1/inhaled-corticosteroids-and-secondary-adrenal-insufficiency-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, among all inhaled glucocorticoids fluticasone propionate is most frequently associated with the development of symptomatic glucocorticoid-induced adrenal insufficiency and exogenous Cushing syndrome (100, 104, 107-111).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [110]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Adrenal crisis can occur not only in patients treated with oral glucocorticoids but also in patients receiving only inhaled (110, 130), topical (131), intra-articular (132), or other glucocorticoid formulations (133).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION
PAUWELS, R. A. (1996) · Arerugī/Arerugi · doi:10.15036/arerugi.45.792 · Cited by 9,994
Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma
Program, P., & theDiagnosis, T. E. P. O. (1997) · Cited by 4,926
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,529 · cited 1×
“1874-3064/14 2014 Bentham Open Keywords: Adrenal insufficiency, adrenal suppression, inhaled corticosteroids.”
Background(2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.029 · Cited by 2,181
Harrison's Principles of Internal Medicine.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-1-167_1 · Cited by 1,523
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Lipworth, B. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.9.941 · Cited by 918 · cited 3×
“It is also not easy to perform when compared with other tests [66, 67].”
BackgroundResultMorosco, G., & Kiley, J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.043 · Cited by 867
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Charmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Research works printed but not linked: 2
- Australian Centre for Asthma Monitoring 2011 Asthma in Austra-lia 2011 with a focus chapter on chronic obstructive pulmonary disease. Asthma series no 4 Cat no ACM 22 Canberra AIHW Available from: http://wwwaihwgov au/publicationdetail/?id=10737420159-0 2011; [cited 7th July 2014]
- Bantle J, Ercan-Fang N, Niewoehner C, Eds. The adrenal cortex. Endocrine pathophysiology Raleigh: Hayes Barton Press. 2004; 2nd ed: pp. pp. 84-108.
Cited by
Porsbjerg, C., Melén, E., Lehtimäki, L., & Shaw, D. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02125-0 · Cited by 575
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L. T., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae029 · Cited by 156
Blakey, J., Chung, L. P., McDonald, V. M., Ruane, L. E., Gornall, J., Barton, C., Bosnic-Anticevich, S. Z., Harrington, J., Hew, M. J., Holland, A. E., et al. (2021) · Respirology · doi:10.1111/resp.14147 · Cited by 114
“Ideally, screening for AI should be undertaken in selected patients with asthma, especially people using high-dose ICS, OCS or both.(111,114) The clinical presentation of AI can vary widely, but often includes non-specific features.”
Background
Metadata
- Authors
- Sannarangappa, V., & Jalleh, R.
- Affiliations
- Modbury Hospital (AU)
- Corresponding author
- Sannarangappa, Vishnu
- ORCID
- Jalleh, Ryan
- Venue
- The Open Respiratory Medicine Journal
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2014-12-31
- Volume
- 8
- Issue
- 1
- Pages
- 93-100
- ISSN
- 1874-3064 (ISSN-L)
- PMC
- PMC4319207
- OpenAlex
- W2023842154
- Cited by
- 49
- References
- 75
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 9 · 2023: 4 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 6 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 1
- FWCI
- 1.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- The Open Respiratory Medicine Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- inhaled corticosteroids, secondary adrenal insufficiency, adrenal suppression, asthma, glucocorticoid suppression, adrenal crisis, screening, adults, children
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhaled Corticosteroids and Secondary Adrenal Insufficiency. https://app.cochat.ai/papers/10.2174/1874306401408010093
- The paper
- Sannarangappa, V., & Jalleh, R. (2014). Inhaled Corticosteroids and Secondary Adrenal Insufficiency. The Open Respiratory Medicine Journal. https://doi.org/10.2174/1874306401408010093
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.